Henoch-Schönlein purpura following hepatitis B vaccination.
The use of recombinant hepatitis B vaccines has led to the effective prevention of hepatitis B infection and its chronic sequelae in immunocompetent individuals. Whilst rare, a variety of serious adverse effects have been reported following vaccination including cutaneous vasculitis in eight previous cases. We describe a case of Henoch-Schönlein purpura developing after hepatitis B vaccination.
Chave
T
T
Department of Dermatology, Leicester Royal Infirmary, Leicester LE1 5WW, UK. toby@chave.fsbusiness.co.uk
Neal
C
C
Camp
R
R
D000328:Adult; D005260:Female; D017325:Hepatitis B Vaccines / Q000009:adverse effects*; D006801:Humans; D011695:IgA Vasculitis / Q000139:chemically induced*
D017325:Hepatitis B Vaccines